Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? : Evidence from two randomised trials with afatinib
Publication date
10/2014Metadata
Show full item recordCitation
Griebsch , I , Palmer , M , Fayers , P M & Ellis , S 2014 , ' Is progression-free survival associated with a better health-related quality of life in patients with lung cancer? Evidence from two randomised trials with afatinib ' , BMJ Open , vol. 4 , no. 10 , e005762 . https://doi.org/10.1136/bmjopen-2014-005762
URI
http://hdl.handle.net/2164/11284http://www.scopus.com/inward/record.url?scp=84911441565&partnerID=8YFLogxK
Rights
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ See: http://creativecommons.org/licenses/by-nc/4.0/